全文获取类型
收费全文 | 159069篇 |
免费 | 15054篇 |
国内免费 | 2193篇 |
专业分类
耳鼻咽喉 | 1118篇 |
儿科学 | 6036篇 |
妇产科学 | 5265篇 |
基础医学 | 12139篇 |
口腔科学 | 2606篇 |
临床医学 | 10822篇 |
内科学 | 19563篇 |
皮肤病学 | 1587篇 |
神经病学 | 3192篇 |
特种医学 | 8150篇 |
外国民族医学 | 204篇 |
外科学 | 17089篇 |
综合类 | 8024篇 |
现状与发展 | 13篇 |
一般理论 | 4篇 |
预防医学 | 3738篇 |
眼科学 | 1618篇 |
药学 | 5903篇 |
62篇 | |
中国医学 | 1170篇 |
肿瘤学 | 68013篇 |
出版年
2024年 | 297篇 |
2023年 | 5533篇 |
2022年 | 8530篇 |
2021年 | 9552篇 |
2020年 | 9708篇 |
2019年 | 6632篇 |
2018年 | 7088篇 |
2017年 | 6473篇 |
2016年 | 6458篇 |
2015年 | 7260篇 |
2014年 | 12903篇 |
2013年 | 11026篇 |
2012年 | 9597篇 |
2011年 | 9060篇 |
2010年 | 9155篇 |
2009年 | 7712篇 |
2008年 | 5321篇 |
2007年 | 5296篇 |
2006年 | 4583篇 |
2005年 | 4066篇 |
2004年 | 3517篇 |
2003年 | 3149篇 |
2002年 | 2930篇 |
2001年 | 2779篇 |
2000年 | 2395篇 |
1999年 | 2223篇 |
1998年 | 1387篇 |
1997年 | 1132篇 |
1996年 | 1120篇 |
1995年 | 934篇 |
1994年 | 709篇 |
1993年 | 611篇 |
1992年 | 1051篇 |
1991年 | 997篇 |
1990年 | 932篇 |
1989年 | 883篇 |
1988年 | 709篇 |
1987年 | 533篇 |
1986年 | 295篇 |
1985年 | 265篇 |
1984年 | 294篇 |
1983年 | 207篇 |
1982年 | 242篇 |
1981年 | 217篇 |
1980年 | 159篇 |
1979年 | 112篇 |
1978年 | 86篇 |
1977年 | 57篇 |
1976年 | 63篇 |
1974年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
11.
12.
13.
14.
《Digestive and liver disease》2020,52(12):1430-1442
Currently, the only curative treatment for cholangiocarcinoma (CCA) is surgical resection, though this treatment is possible in less than 40% of patients. However, recent improvements in preoperative management have led to a higher number of patients who are candidates for this procedure. For unresectable patients, progress is ongoing in terms of locoregional and chemoradiation treatments and target therapies, especially in the definition of patient selection criteria. This is the second part of the Italian CCA guidelines, dealing with CCA treatment, that have been formulated in accordance with Italian National Institute of Health indications and developed according to the GRADE method and related advancements. 相似文献
15.
16.
Sathiyavelavan Gopalan Jagadesh Chandra Bose S. Periasamy 《The Indian journal of surgery》2015,77(3):232-236
The aim of this study is to review the literature to find out the exact etiology of anastomotic cancers of colon post resection and differentiate them between a recurrence, second primary, and metastatic disease (local manifestation of systemic disease). Web-based literature search was done, and datas collected. We searched PubMed for papers using the keywords colon cancer recurrence, anastomotic recurrence, and recurrent colon carcinoma. We also searched for systematic review in the same topic. In addition, we used our personal referrence archive. Anastomotic recurrences of colon are postulated to arise due to inadequate margins, tumor implantation by exfoliated cells, altered biological properties of bowel anastomosis, and missed synchronous lesions. Some tumors are unique with repeated recurrence after repeated resection. Duration after primary surgery plays a major role in differentiating recurrent and second primary lesions. Repeated recurrences after repeated resections have to be considered a manifestation of systemic disease or metastatic disease due to the virulence of the disease. A detailed analysis and study of patients with colonic anastomotic lesion are required to differentiate it between a recurrent, a second primary lesion, and a metastatic disease (local manifestation of a systemic disease). The nomenclature is significant to study the survival of these patients, as a second primary lesion will have different survival compared to that of recurrent lesions. 相似文献
17.
《Mayo Clinic proceedings. Mayo Clinic》2019,94(7):1321-1329
Immune checkpoint inhibitors are molecules that increase the endogenous immune response against tumors. They have revolutionized the field of oncology. Since their initial approval for the treatment of advanced melanoma, their use has expanded to the treatment of several other advanced cancers. Unfortunately, immune checkpoint inhibitors have also been associated with the emergence of a new subset of autoimmune-like toxicities, known as immune-related adverse events. These toxicities differ depending on the agent, malignancy, and individual susceptibilities. Although the skin and colon are most commonly involved, any organ may be affected, including the liver, lungs, kidneys, and heart. Most of these toxicities are diagnosed by excluding other secondary infectious or inflammatory causes. Corticosteroids are commonly used for treatment of moderate and severe immune-related adverse events, although additional immunosuppressive therapy may occasionally be required. The occurrence of immune-related toxicities may require discontinuation of immunotherapy, depending on the specific toxicity and its severity. In this article, we provide a focused review to familiarize practicing clinicians with this important topic given that the use of immune checkpoint inhibitors continues to increase. 相似文献
18.
19.
《Ophthalmology》2020,127(11):1498-1506
20.
《Mayo Clinic proceedings. Mayo Clinic》2022,97(12):2271-2281
ObjectiveTo investigate the association between type 1 diabetes mellitus (T1D) and type 2 diabetes mellitus (T2D) with risk of sudden cardiac arrest (SCA).MethodsIn a prospective community-based study of SCA from February 1, 2002, through November 30, 2019, we ascertained 2771 cases age 18 years of age or older and matched them to 8313 controls based on geography, age, sex, and race/ethnicity. We used logistic regression to evaluate the independent association between diabetes, T1D, T2D, and SCA.ResultsPatients had a mean age of 64.5±15.9 years, were 33.3% female and 23.9% non-White race. Overall, 36.7% (n=1016) of cases and 23.8% (n=1981) of controls had diabetes. Among individuals with diabetes, the proportion of T1D was 6.5% (n=66) among cases and 2.0% among controls (n=40). Diabetes was associated with 1.5-times higher odds of SCA. Compared with those without diabetes, the odds ratio and 95% CI for SCA was 4.36 (95% CI, 2.81 to 6.75; P<.001) in T1D and 1.45 (95% CI, 1.30 to 1.63; P<.001) in T2D after multivariable adjustment. Among those with diabetes, the odds of having SCA were 2.41 times higher in T1D than in T2D (95% CI, 1.53 to 3.80; P<.001). Cases of SCA with T1D were more likely to have an unwitnessed arrest, less likely to receive resuscitation, and less likely to survive compared with those with T2D.ConclusionType 1 diabetes was more strongly associated with SCA compared with T2D and had less favorable outcomes following resuscitation. Diabetes type could influence the approach to risk stratification and prevention of SCA. 相似文献